National Institute of Standards and Technology Awards $2 Million to 20/20 GeneSystems, Inc. for Innovative Tumor Profiling Technology

ROCKVILLE, Md.--(BUSINESS WIRE)--20/20 GeneSystems, Inc. (“20/20”) announced today that the National Institute of Standards and Technology (NIST) Advanced Technology Program (ATP) has awarded $1.9 million to 20/20 GeneSystems for the development of a technique known as Layered Expression Scanning-Diagnostic (LES-Dx) for tumor profiling to better predict whether cancer patients will respond to certain “personalized” chemotherapy drugs.